Loading...
Market
Will PresVu eye drops receive a major international award for innovation in pharmaceuticals by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from recognized award organizations
Story
DCGI Approves ENTOD Pharmaceuticals' PresVu Eye Drops to Reduce Dependency on Reading Glasses
Sep 4, 2024, 03:40 AM
The Drug Controller General of India (DCGI) has approved new eye drops developed by ENTOD Pharmaceuticals, designed to reduce the dependency on reading glasses for individuals with presbyopia. The eye drops, named PresVu, have been under deliberation for over two years before receiving final approval. This marks India’s first eye drops aimed at eliminating the need for reading glasses.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Best New Drug • 25%
Innovation in Oncology • 25%
No major award • 25%
Other • 25%
Amgen • 25%
Regeneron • 25%
Novartis • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Nobel Prize • 25%
Lasker Award • 25%
Breakthrough Prize • 25%
No award • 25%